On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis
, and others.
Food and Drug Administration today approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis
(a narrowing of the heart's aortic valve that restricts blood flow to aorta, the body's main artery) who are at low risk for death or major complications associated with open-heart surgery to replace the damaged valves.
Food and Drug Administration approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis
(a narrowing of the hearts aortic valve that restricts blood flow to aorta, the bodys main artery) who are at low risk for death or major complications associated with open-heart surgery to replace the damaged valves.
Food and Drug Administration announced today that certain transcatheter heart valves are now approved for use in patients with severe aortic valve stenosis
who have a low risk for death or major complications during open-heart surgery.
High prevalence of structural heart diseases, increase in demand for minimally invasive procedures, rise in in research & development initiatives, and surge in awareness about valve regurgitation and valve stenosis
are factors driving the global structural heart devices market.
In particular, the study published in the European Heart Journal, shows that as body mass index (BMI) and fat mass increase, so does the risk of aortic valve stenosis
- a condition in which the valve controlling the flow of blood from the heart to the body's largest blood vessel, the aorta, narrows and fails to open fully.
For every one unit rise in BMI, the risk of disease ranged from 6% for pulmonary embolism to 13% for aortic valve stenosis
. Prof Susanna Larsson, of the Karolinska Institute in Sweden, did the research.
The days of open-heart surgery to treat aortic valve stenosis
may be limited, according to two ground-breaking studies presented at the 2019 American College of Cardiology (ACC) Annual Scientific Session.
Aortic valve stenosis
is the process of thickening and stiffening in the aortic valve, which can result in an abnormal narrowing of the aortic valve opening and reduction in blood flow.
The patient recently began experiencing symptoms of mitral valve stenosis
And third, bicuspid aortic valve and aortic valve stenosis
: The aortic valve of this baby is abnormal and narrow."
The Mayo Clinic defines it as "a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis
)." The procedure involves wedging a replacement valve into the aortic valve's place.